Europe, Middle East, and Africa Point-of-Care Diagnostics Market Size, Share & Trends Report

Europe, Middle East, and Africa Point-of-Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Blood Gas, Infectious Diseases, Hospital Glucose Testing, Cardiac Markers, Hematology, Coagulation, Primary Care Systems, Decentralized Clinical Chemistry, Urinalysis, Drug Abuse Testing) And Segment Forecasts To 2022

  • Published Date: Jan 2016
  • Report ID: 978-1-68038-806-0
  • Number of Pages: 174
  • Format: Electronic (PDF)
  • Historical Data: 2013-2015

Table of Content

Chapter 1 Research Methodology & Scope
                    1.1 Research Methodology
                    1.2 Research Scope & Assumptions
                    1.3 Country Wise Market Calculation
                       1.3.1 Country Wise Market: Base Estimates
                       1.3.2 Global Market: CAGR Calculation
                    1.4 Region-based segment share calculation
                    1.5 List of Secondary Sources
                    1.6 List of Primary Sources
Chapter 2 Executive Summary
Chapter 3 EMEA Point-of-Care (PoC) Diagnostics Industry Outlook
                    3.1 Market segmentation
                    3.2 Market Size and Growth Prospects
                    3.3 EMEA point-of-care diagnostics - Market dynamics
                       3.3.1 Market driver analysis
                            3.3.1.1 Growing geriatric population base
                            3.3.1.2 Growing prevalence of target diseases
                            3.3.1.3 Growing demand for home healthcare and introduction of advanced technology-enabled products
                            3.3.1.4 Other drivers
                       3.3.2 Market restraint analysis
                            3.3.2.1 High procedure costs
                            3.3.2.2 Presence of ambiguous regulatory framework
                    3.4 Key opportunities - Prioritized
                    3.5 Industry Analysis - Porter’s
                    3.6 EMEA Point-of-Care Diagnostics - Company Market Share/Competitive Landscape, 2014
                    3.7 EMEA point-of-care diagnostics market - PESTEL Analysis
                    3.8 EMEA Point-of-Care Diagnostics Market - Technology Development Analysis
                       3.8.1 Patient Self-testing
                       3.8.2 Clinical Laboratory Testing
                       3.8.3 Near-patient Testing
Chapter 4 EMEA Point-of-Care Diagnostics Product Outlook
                    4.1 EMEA point-of-care diagnostics market share by product, 2014 & 2022
                    4.2 Glucose testing
                       4.2.1 PoC glucose testing market, 2012 to 2022 (USD Million)
                       4.2.2 Over The Counter (OTC) glucose testing market, 2012 to 2022 (USD Million)
                       4.2.3 Prescribed glucose testing market, 2012 to 2022 (USD Million)
                    4.3 Cardiac markers
                       4.3.1 PoC cardiac markers market, 2012 - 2022 (USD Million)
                    4.4 Fertility
                       4.4.1 PoC fertility diagnostics market, 2012 - 2022 (USD Million)
                    4.5 Blood gas and electrolytes
                       4.5.1 PoC blood gas and electrolytes diagnostics market, 2012 - 2022, (USD Million)
                    4.6 Decentralized clinical chemistry
                       4.6.1 PoC decentralized clinical chemistry diagnostics market, 2012 - 2022 (USD million)
                    4.7 Infectious disease testing
                       4.7.1 PoC infectious disease testing market, 2012 - 2022 (USD Million)
                    4.8 Coagulation
                       4.8.1 PoC coagulation diagnostics market, 2012 - 2022 (USD million)
                       4.8.2 Over The Counter (OTC) coagulation diagnostics market, 2012 - 2022 (USD million)
                       4.8.3 Prescribed coagulation diagnostics market, 2012 - 2022 (USD million)
                    4.9 Primary care systems
                       4.9.1 PoC primary care systems market, 2012 - 2022 (USD Million)
                    4.10 Hematology
                       4.10.1 PoC hematology market, 2012 - 2022 (USD Million)
                    4.11 Urinalysis
                       4.11.1 PoC urinalysis market, 2012 - 2022 (USD Million)
                    4.12 Drug abuse testing
                       4.12.1 PoC drug abuse testing market, 2012 - 2022 (USD Million)
                    4.13 Other
                       4.13.1 Other PoC testing market, 2012 - 2022 (USD Million)
Chapter 5 EMEA Point of Care Diagnostics End-use Outlook
                    5.1 Hospitals
                       5.1.1 Hospital-based PoC diagnostics market, 2012 - 2022 (USD million)
                    5.2 Clinics
                       5.2.1 Clinics-based PoC diagnostics market, 2012 - 2022 (USD million)
                    5.3 Laboratories
                       5.3.1 Laboratories-based PoC diagnostics market, 2012 - 2022 (USD million)
                    5.4 Assisted living healthcare facilities
                       5.4.1 Assisted living healthcare facilities-based PoC diagnostics market, 2012 - 2022 (USD million)
                    5.5 Home healthcare
                       5.5.1 Home healthcare-based PoC diagnostics market, 2012 - 2022 (USD million)
                    5.6 Others
                       5.6.1 Other healthcare establishments-based PoC diagnostics market, 2012 - 2022 (USD million)
Chapter 6 EMEA Point-of-Care Diagnostics Regional Outlook
                    6.1 Europe point-of-care diagnostics market share by region, 2014 & 2022
                    6.2 Europe
                       6.2.1 Europe PoC diagnostics market, 2012 - 2022 (USD Million)
                       6.2.2 Germany
                            6.2.2.1 Germany PoC diagnostics market, 2012 - 2022 (USD Million)
                       6.2.3 Benelux Union
                            6.2.3.1 Benelux Union PoC diagnostics market, 2012 - 2022 (USD Million)
                            6.2.3.2 Belgium
                                    6.2.3.2.1 Belgium PoC diagnostics market, 2012 - 2022 (USD Million)
                            6.2.3.3 Netherlands
                                    6.2.3.3.1 Netherlands PoC diagnostics market, 2012 - 2022 (USD Million)
                            6.2.3.4 Luxembourg
                                    6.2.3.4.1 Luxembourg PoC diagnostics market, 2012 - 2022 (USD Million)
                       6.2.4 France
                            6.2.4.1 France PoC diagnostics market, 2012 - 2022 (USD Million)
                       6.2.5 Spain
                            6.2.5.1 SpainPoC diagnostics market, 2012 - 2022 (USD Million)
                       6.2.6 Portugal
                            6.2.6.1 PortugalPoC diagnostics market, 2012 - 2022 (USD Million)
                       6.2.7 Italy
                            6.2.7.1 ItalyPoC diagnostics market, 2012 - 2022 (USD Million)
                       6.2.8 Scandinavia
                            6.2.8.1 Scandinavia PoC diagnostics market, 2012 - 2022 (USD Million)
                            6.2.8.2 Denmark
                                    6.2.8.2.1 Denmark PoC diagnostics market, 2012 - 2022 (USD Million)
                            6.2.8.3 Norway
                                    6.2.8.3.1 Norway PoC diagnostics market, 2012 - 2022 (USD Million)
                            6.2.8.4 Sweden
                                    6.2.8.4.1 Sweden PoC diagnostics market, 2012 - 2022 (USD Million)
                            6.2.8.5 Finland
                                    6.2.8.5.1 Finland PoC diagnostics market, 2012 - 2022 (USD Million)
                       6.2.9 UK
                            6.2.9.1 UK PoC diagnostics market, 2012 - 2022 (USD Million)
                       6.2.10 Turkey
                            6.2.10.1 Turkey PoC diagnostics market, 2012 - 2022 (USD Million)
                       6.2.11 Rest of Europe
                            6.2.11.1 Rest of Europe PoC diagnostics market, 2012 - 2022 (USD Million)
                    6.3 Middle East and Africa (MEA) point-of-care diagnostics market share by region, 2014 & 2022
                    6.4 Middle East and Africa
                       6.4.1 Middle East and Africa (MEA) PoC diagnostics market, 2012 - 2022 (USD Million)
                       6.4.2 South Africa
                            6.4.2.1 South Africa PoC diagnostics market, 2012 - 2022 (USD Million)
                       6.4.3 Nigeria
                            6.4.3.1 Nigeria PoC diagnostics market, 2012 - 2022 (USD Million)
                       6.4.4 Kenya
                            6.4.4.1 Kenya PoC diagnostics market, 2012 - 2022 (USD Million)
                       6.4.5 Zimbabwe
                            6.4.5.1 Zimbabwe PoC diagnostics market, 2012 - 2022 (USD Million)
                       6.4.6 Saudi Arabia
                            6.4.6.1 Saudi Arabia PoC diagnostics market, 2012 - 2022 (USD Million)
                       6.4.7 United Arab Emirates
                            6.4.7.1 United Arab Emirates PoC diagnostics market, 2012 - 2022 (USD Million)
                       6.4.8 Qatar
                            6.4.8.1 Qatar PoC diagnostics market, 2012 - 2022 (USD Million)
                       6.4.9 Rest of MEA
                            6.4.9.1 Rest of MEA PoC diagnostics market, 2012 - 2022 (USD Million)
Chapter 7 Competitive Landscape
                    7.1 Roche Diagnostics
                       7.1.1 Company Overview
                       7.1.2 Financial Performance
                       7.1.3 Product Benchmarking
                       7.1.4 Strategic Initiatives
                    7.2 Abbott
                       7.2.1 Company Overview
                       7.2.2 Financial Performance
                       7.2.3 Product Benchmarking
                       7.2.4 Strategic Initiatives
                    7.3 Siemens Healthcare
                       7.3.1 Company Overview
                       7.3.2 Financial Performance
                       7.3.3 Product Benchmarking
                       7.3.4 Strategic Initiatives
                    7.4 Danaher Corporation (Beckman Coulter Inc.)
                       7.4.1 Company Overview
                       7.4.2 Financial Performance
                       7.4.3 Product Benchmarking
                       7.4.4 Strategic Initiatives
                    7.5 Becton Dickinson and Company
                       7.5.1 Company Overview
                       7.5.2 Financial Performance
                       7.5.3 Product Benchmarking
                       7.5.4 Strategic Initiatives
                    7.6 bioMerieux S.A.
                       7.6.1 Company Overview
                       7.6.2 Financial Performance
                       7.6.3 Product Benchmarking
                       7.6.4 Strategic Initiatives
                    7.7 Johnson & Johnson
                       7.7.1 Company Overview
                       7.7.2 Financial Performance
                       7.7.3 Product Benchmarking
                       7.7.4 Strategic Initiatives
                    7.8 Abaxis, Inc.
                       7.8.1 Company Overview
                       7.8.2 Financial Performance
                       7.8.3 Product Benchmarking
                       7.8.4 Strategic Initiatives
                    7.9 Alere, Inc.
                       7.9.1 Company Overview
                       7.9.2 Financial Performance
                       7.9.3 Product Benchmarking
                       7.9.4 Strategic Initiatives
                    7.10 Qiagen N.V. (AmniSure)
                       7.10.1 Company Overview
                       7.10.2 Financial Performance
                       7.10.3 Product Benchmarking
                       7.10.4 Strategic Initiatives
                    7.11 Spectral Diagnostics Inc.
                       7.11.1 Company Overview
                       7.11.2 Financial Performance
                       7.11.3 Product Benchmarking
                       7.11.4 Strategic Initiatives
                    7.12 Trinity Biotech PLC
                       7.12.1 Company Overview
                       7.12.2 Financial Performance
                       7.12.3 Product Benchmarking
                       7.12.4 Strategic Initiatives
                    7.13 Nipro Diagnostics, Inc.
                       7.13.1 Company Overview
                       7.13.2 Financial Performance
                       7.13.3 Product Benchmarking
                       7.13.4 Strategic Initiatives
                    7.14 HemoCue AB
                       7.14.1 Company Overview
                       7.14.2 Financial Performance
                       7.14.3 Product Benchmarking
                       7.14.4 Strategic Initiatives
                    7.15 Nova Biomedical
                       7.15.1 Company Overview
                       7.15.2 Financial Performance
                       7.15.3 Product Benchmarking
                       7.15.4 Strategic Initiatives
                    7.16 International Technidyne Corporation (ITC)
                       7.16.1 Company Overview
                       7.16.2 Financial Performance
                       7.16.3 Product Benchmarking
                       7.16.4 Strategic Initiatives
                    7.17 Quidel Corporation
                       7.17.1 Company Overview
                       7.17.2 Financial Performance
                       7.17.3 Product Benchmarking
                       7.17.4 Strategic Initiatives
                    7.18 Sekisui Diagnostics
                       7.18.1 Company Overview
                       7.18.2 Financial Performance
                       7.18.3 Product Benchmarking
                       7.18.4 Strategic Initiatives
                    7.19 OraSure Technologies
                       7.19.1 Company Overview
                       7.19.2 Financial Performance
                       7.19.3 Product Benchmarking
                       7.19.4 Strategic Initiatives
Chapter 8 Methodology and Scope
                    8.1 List of Data Sources


List of Tables

TABLE 1 Country share estimation
TABLE 2 EMEA Point-of-Care Diagnostics Market - Industry Summary & Critical Success Factors (CSFs)
TABLE 3 EMEA point-of-care diagnostics market, by product, 2012 - 2020 (USD Million)
TABLE 4 EMEA Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 5 EMEA Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 6 EMEA point-of-care diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 7 EMEA point-of-care diagnostics market, by region, 2012 - 2020 (USD Million)
TABLE 8 EMEA point-of-care diagnostics - Key market driver analysis
TABLE 9 Europe Diabetes Prevalence (national prevalence %), 2014 & 2035
TABLE 10 MENA and Africa Diabetes Prevalence (national %prevalence)
TABLE 11 Point-of-care solutions, by segment
TABLE 12 EMEA point-of-care diagnostics- Key market restraint analysis
TABLE 13 Europe PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 14 Europe Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 15 Europe Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 16 Europe PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 17 Germany PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 18 Germany Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 19 Germany Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 20 Germany PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 21 Benelux Union PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 22 Benelux Union Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 23 Benelux Union Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 24 Benelux Union PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 25 Belgium PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 26 Belgium Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 27 Belgium Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 28 Belgium PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 29 Netherlands PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 30 Netherlands Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 31 Netherlands Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 32 Netherlands PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 33 Luxembourg PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 34 Luxembourg point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 35 Luxembourg point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 36 Luxembourg PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 37 France PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 38 France Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 39 France Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 40 France PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 41 Spain PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 42 Spain Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 43 Spain Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 44 Spain PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 45 Portugal PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 46 Portugal Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 47 Portugal Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 48 Portugal PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 49 Italy PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 50 Italy Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 51 Italy Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 52 Italy PoC diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 53 Scandinavia PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 54 Scandinavia Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 55 Scandinavia Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 56 Scandinavia PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 57 Denmark PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 58 Denmark Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 59 Denmark Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 60 Denmark PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 61 Norway PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 62 Norway Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 63 Norway Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 64 Norway PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 65 Sweden PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 66 Sweden Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 67 Sweden Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 68 Sweden PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 69 Finland PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 70 Finland Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 71 Finland Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 72 Finland PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 73 UK PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 74 UK Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 75 UK Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 76 UK PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 77 Turkey PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 78 Turkey Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 79 Turkey Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 80 Turkey PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 81 Rest of Europe PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 82 Rest of Europe Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 83 Rest of Europe Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 84 Rest of Europe PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 85 MEA PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 86 MEA Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 87 MEA Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 88 MEA PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 89 South Africa PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 90 South Africa Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 91 South Africa Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 92 South Africa PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 93 Nigeria PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 94 Nigeria Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 95 Nigeria Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 96 Nigeria PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 97 Kenya PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 98 Kenya Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 99 Kenya Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 100 Kenya PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 101 Zimbabwe PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 102 Zimbabwe Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 103 Zimbabwe Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 104 Zimbabwe PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 105 Saudi Arabia PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 106 Saudi Arabia Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 107 Saudi Arabia Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 108 Saudi Arabia PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 109 United Arab Emirates PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 110 United Arab Emirates Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 111 United Arab Emirates Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 112 United Arab Emirates PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 113 Qatar PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 114 Qatar Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 115 Qatar Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 116 Qatar PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)
TABLE 117 Rest of MEA PoC diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 118 Rest of MEA Point of care glucose testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 119 Rest of MEA Point of care coagulation testing diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 120 Rest of MEA PoC diagnostics market, by end-use, 2012 - 2020 (USD Million)


List of Figures

FIG. 1 EMEA point-of-care diagnostics: Market segmentation
FIG. 2 EMEA point-of-care diagnostics market, (USD Million), 2012 - 2022
FIG. 3 EMEA point-of-care diagnostics: Market dynamics
FIG. 4 Population over the age of 65, by region, 2010 and 2050
FIG. 5 Diabetes (%) prevalence in EMEA, 2014
FIG. 6 Key opportunities - Prioritized
FIG. 7 EMEA point-of-care diagnostics market- Porter’s analysis
FIG. 8 POC diagnostics: Company market share analysis, 2014
FIG. 9 EMEA point-of-care diagnostics market - PESTEL Analysis
FIG. 10 EMEA point-of-care diagnostics market trend
FIG. 11 PoC diagnostics market share by product, 2014 & 2022
FIG. 12 PoC glucose testing market, 2012 - 2022 (USD Million)
FIG. 13 Over The Counter (OTC) glucose testing market, 2012 - 2022 (USD Million)
FIG. 14 Prescribed glucose testing market, 2012 - 2022 (USD Million)
FIG. 15 PoC cardiac markers market, 2012 - 2022 (USD Million)
FIG. 16 PoC fertility diagnostics market, 2012 - 2022 (USD Million)
FIG. 17 PoC blood gas and electrolytes diagnostics market, 2012 - 2022 (USD Million)
FIG. 18 PoC decentralized clinical chemistry diagnostics market, 2012 - 2022 (USD Million)
FIG. 19 PoC infectious disease testing market, 2012 - 2022 (USD Million)
FIG. 20 PoC coagulation diagnostics market, 2012 - 2022 (USD Million)
FIG. 21 Over The Counter (OTC) coagulation diagnostics market, 2012 - 2022 (USD Million)
FIG. 22 Prescribed coagulation diagnostics market, 2012 - 2022 (USD Million)
FIG. 23 PoC primary care systems market, 2012 - 2022 (USD Million)
FIG. 24 PoC hematology market, 2012 - 2022 (USD Million)
FIG. 25 PoC urinalysis market, 2012 - 2022 (USD Million)
FIG. 26 PoC drug abuse market, 2012 - 2022 (USD Million)
FIG. 27 Other PoC market, 2012 - 2022 (USD Million)
FIG. 28 EMEA point-of-care diagnostics market share by end-use, 2014 & 2022
FIG. 29 Hospital-based PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 30 Clinics-based PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 31 Laboratories-based PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 32 Assisted living healthcare facilities-based PoC diagnostics market, 2012 - 2022 (USD million)
FIG. 33 Home healthcare-based PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 34 Other healthcare establishments-based PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 35 Europe point-of-care diagnostics market share by region, 2014 & 2022
FIG. 36 Europe PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 37 Germany PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 38 Benelux Union PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 39 Belgium PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 40 Netherlands PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 41 Luxembourg PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 42 France PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 43 Spain PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 44 Portugal PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 45 Italy PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 46 Scandinavia PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 47 Denmark PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 48 Norway PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 49 Sweden PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 50 Finland PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 51 UK PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 52 Turkey PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 53 Rest of Europe PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 54 Middle East and Africa (MEA) point-of-care diagnostics market share by region, 2014 & 2022
FIG. 55 Middle East and Africa (MEA) PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 56 South Africa PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 57 Nigeria PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 58 Kenya PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 59 Zimbabwe PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 60 Saudi Arabia PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 61 United Arab Emirates PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 62 Qatar PoC diagnostics market, 2012 - 2022 (USD Million)
FIG. 63 Rest of MEA PoC diagnostics market, 2012 - 2022 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.